Cytomegalovirus enterocolitis in a patient with diffuse large B-cell lymphoma after chemotherapy with rituximab

被引:3
作者
Seewoodhary, Jason [1 ]
机构
[1] Univ Wales Hosp, Cardiff CF14 4XW, S Glam, Wales
关键词
rituximab; cytomegalovirus; enterocolitis; diffuse large B-cell lymphoma; immunosuppression;
D O I
10.3748/wjg.v12.i45.7391
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Rituximab has been associated with the development of cytomegalovirus enterocolitis in immunosuppressed patients. A 51-year-old patient with diffuse large B-cell lymphoma who received a conditioning chemotherapy regimen (RCVP and RICE) consisting of rituximab before bone marrow transplantation went on to develop cytomegalovirus enterocolitis. This supports evidence from previously described cases that rituximab may be associated with cytomegalovirus enterocolitis. (c) 2006 The WIG Press. All rights reserved.
引用
收藏
页码:7391 / 7391
页数:1
相关论文
共 2 条
[1]   Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy [J].
Czuczman, MS ;
Grillo-López, AJ ;
White, CA ;
Saleh, M ;
Gordon, L ;
LoBuglio, AF ;
Jonas, C ;
Klippenstein, D ;
Dallaire, B ;
Varns, C .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :268-276
[2]   Cytomegalovirus gastritis after rituximab treatment in a non-Hodgkin's lymphoma patient [J].
Unluturk, Ugur ;
Aksoy, Sercan ;
Yonem, Ozlem ;
Bayraktar, Yusuf ;
Tekuzman, Gulten .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (12) :1978-1979